Submission Details
| 510(k) Number | K220162 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 20, 2022 |
| Decision Date | February 18, 2022 |
| Days to Decision | 29 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K220162 is an FDA 510(k) clearance for the Noveos Immunoanalyzer System, Noveos Specific IgE (sIgE), Capture Reagent M006, Alternaria, a System, Test, Radioallergosorbent (rast) Immunological (Class II — Special Controls, product code DHB), submitted by Hycor Biomedical (Garden Grove, US). The FDA issued a Cleared decision on February 18, 2022, 29 days after receiving the submission on January 20, 2022. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5750.
| 510(k) Number | K220162 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 20, 2022 |
| Decision Date | February 18, 2022 |
| Days to Decision | 29 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | DHB — System, Test, Radioallergosorbent (rast) Immunological |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5750 |